SMJ Article | Review Article

Alpelisib-Induced Hyperglycemia in PIK3CA+ Breast Cancer Patients

Alpelisib is a phosphatidylinositol 3-kinase inhibitor approved by the US Food and Drug Administration for the treatment of hormone receptor–positive metastatic breast cancer with PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α) mutation. In recent years a number of adverse effects have been observed to be associated with this therapy, the most...

Posted in: Breast Cancer3

SMJ Article | Original Article

Cancer Screening Prevalence and Preference among Hospitalized Women With and Without Obesity

Objectives: This study explored the prevalence of nonadherence and preferences for breast cancer (BRC) and colorectal cancer (CRC) screening among hospitalized women with and without obesity who were cancer-free at baseline. In addition, the study evaluated risk factors associated with nonadherence among hospitalized women with obesity. Methods: A prospective interventional...

Posted in: Breast Cancer3

Abstract | May 4, 2021

A Rare Complication of Breast Cancer Treatment: Radiation Induced Sarcoma

Sarcomas are a rare type of tumor that account for about one percent of all cancer, arises from mesenchymal cells, and are often asymptomatic until they become very large. Post-radiation sarcomas, or radiation induced sarcomas (RIS), are rare complications of radiotherapy that occur within a previously irradiated field over a latency period of 10 to 15 years.

Posted in: Medical Oncology17 Breast Cancer2

Abstract | November 13, 2020

Beyond The Barriers: A Case Series On Advanced Stage Breast and Gynecologic Cancer In New Orleans

Breast and gynecologic cancer screenings are available to a wide population of female patients through insurance providers and various support programs, however these cancers remain prevalent in our population today. In the context of screening availability, barriers leading to late/end-stage breast and gynecologic cancers must be explored. This report aims to highlight unique barriers that contribute to presentation with late-stage breast and gynecologic cancer in women of low socioeconomic status.

Posted in: Medical Oncology17 Women’s & Children’s Health30 Breast Cancer2 Gynecologic Cancer1

SMJ Article | Original Article

Less Toxic Chemotherapy in Locally Advanced Breast Cancer

Objectives: Preoperative chemotherapy produces tumor shrinkage in most patients with locally advanced breast cancer, including some pathological complete responses (pCRs). We attempted this using a much less toxic sequential regimen, given with concurrent bevacizumab. Methods: Patients with locally advanced breast cancer received 3 intravenous doses each of preoperative sequential liposome...

Posted in: Medical Oncology24 Breast Cancer3
SMA Menu